Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trial
Jenkin D., Ritchie AJ., Aboagye J., Fedosyuk S., Thorley L., Provstgaad-Morys S., Sanders H., Bellamy D., Makinson R., Xiang ZQ., Bolam E., Tarrant R., Ramos Lopez F., Platt A., Poulton I., Green C., Ertl HCJ., Ewer KJ., Douglas AD.